UK markets open in 4 hours 23 minutes

Oragenics, Inc. (0A64.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.0165-0.1830 (-15.26%)
At close: 02:52PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 3-52.60%
S&P500 52-week change 325.01%
52-week high 37.4500
52-week low 30.0000
50-day moving average 33.8565
200-day moving average 33.6138

Share statistics

Avg vol (3-month) 3357
Avg vol (10-day) 3434
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 83.95M
% held by insiders 123.23%
% held by institutions 17.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.016667:1
Last split date 323 Jan 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-55,519.89%

Management effectiveness

Return on assets (ttm)-132.48%
Return on equity (ttm)-255.36%

Income statement

Revenue (ttm)37.65k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -20.88M
Net income avi to common (ttm)-20.66M
Diluted EPS (ttm)-0.1420
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.48M
Total cash per share (mrq)0.78
Total debt (mrq)322.51k
Total debt/equity (mrq)10.18%
Current ratio (mrq)2.15
Book value per share (mrq)0.51

Cash flow statement

Operating cash flow (ttm)-7.29M
Levered free cash flow (ttm)-9.23M